<DOC>
	<DOCNO>NCT00864045</DOCNO>
	<brief_summary>The purpose study assess efficacy safety sertindole patient schizophrenia Asia .</brief_summary>
	<brief_title>Sertindole Asian Patients With Schizophrenia</brief_title>
	<detailed_description>This study first randomise clinical trial perform Asia sertindole , aim compare sertindole efficacy safety another atypical antipsychotic . Sertindole limbic-selective antipsychotic agent unique neuropharmacological profile . Sertindole show significant improvement relative placebo positive negative symptom schizophrenia ( measure PANSS total , PANSS negative positive subscale score ) . It well tolerate show placebo-level incidence extrapyramidal symptom ( EPS ) . Sertindole associate dose-dependent increase QT interval , translate excess mortality sertindole relative recently develop antipsychotic respective clinical development programme .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<mesh_term>Sertindole</mesh_term>
	<criteria>Male female patient , age 1865 year ( extremes include ) , suffer schizophrenia Positive Negative Syndrome Scales ( PANSS ) total score 60 120 ( extreme include ) screen baseline Based patient 's clinical status , antipsychotic treatment indicated Otherwise healthy Female patient nonchildbearing potential , nonpregnant , breastfeed woman childbearing potential , use adequate birth control method Current Axis I primary psychiatric diagnosis schizophrenia Has never receive antipsychotic drug Has receive depot antipsychotic medication within less one dose interval prior Screening History clinically significant cardiovascular disease , congestive heart failure , cardiac hypertrophy , arrhythmia bradycardia ( &lt; 50 beat per minute ) Congenital long QT syndrome family history disease , patient know acquire QT interval prolongation ( QTc 450 msec male 470 msec female Screening ) Significant risk suicide and/or violent behaviour Known history narrow angle glaucoma Substance alcohol abuse , current alcohol dependence Use disallow concomitant medication Other protocoldefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>